文献速递前列腺癌

全身磁共振成像用于前列腺癌分期:一项叙述性综述

Whole-body MRI for staging prostate cancer: a narrative review.
PubMed 文献 · BJU Int · 2024-09-22

本叙述性综述经PubMed检索评估全身磁共振成像(WBMRI)在高危前列腺癌(HRPCa)分期中的诊断准确性。WBMRI在检测淋巴结转移方面与CT相当甚至更优,在骨转移检测上优于骨闪烁显像,但诊断转移性疾病的性能不及PSMA PET/CT。需要进一步研究WBMRI与PSMA PET/CT的成本比较以及联合PSMA PET/MRI的评估。

要点

  • WBMRI检测高危前列腺癌淋巴结转移的敏感性和特异性与CT相当甚至更优。
  • WBMRI检测骨转移的敏感性和特异性优于骨闪烁显像。
  • WBMRI检测转移性疾病的诊断性能不及PSMA PET/CT。

核心结论

  • WBMRI在检测高危前列腺癌患者转移性疾病方面的诊断能力超过传统CT和骨闪烁显像。
  • WBMRI的诊断性能不及PSMA PET/CT。
  • 需要进一步研究WBMRI与PSMA PET/CT的成本比较以及联合PSMA PET/MRI的评估。

研究设计与样本

  • 叙述性综述,经PubMed检索关键词包括「全身」「磁共振成像」「MRI」「前列腺癌」「风险分层」和「分期」。
  • 纳入评估WBMRI用于高危前列腺癌分期成像的文章,排除仅评估生化复发或转移性疾病进展的研究。

主要发现

  • 在淋巴结转移评估中,WBMRI的敏感性和特异性与CT传统成像相比相当甚至更优。
  • WBMRI检测骨转移的敏感性和特异性优于骨闪烁显像。
  • 随着PSMA放射性配体用于PET,WBMRI检测转移性疾病的诊断性能似乎较差。

局限性

  • 需要进一步研究WBMRI与PSMA PET/CT的成本比较以及联合PSMA PET/MRI的评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To present a narrative review regarding the diagnostic accuracy of whole-body magnetic resonance imaging (WBMRI) in staging patients with high-risk prostate cancer (HRPCa) and compare it to established imaging modalities. METHODS: A narrative review was carried out using PubMed using the following keywords: 'whole body', 'magnetic resonance imaging', 'MRI', 'prostate cancer', 'risk stratification', and 'staging'. Articles that evaluated WBMRI as the imaging modality to stage patients with HRPCa were included, while studies that solely assessed for biochemical recurrence or metastatic disease progression were excluded. RESULTS: In the evaluation of lymphatic metastases, WBMRI has demonstrated a comparable, if not improved, sensitivity and specificity compared to conventional imaging of computed tomography (CT). Furthermore, WBMRI demonstrates improved sensitivity and specificity in detecting bone metastases compared to bone scintigraphy (BS). However, with advent of prostate-specific membrane antigen (PSMA) radioligands for positron emission tomography (PET), the diagnostic performance of WBMRI to detect metastatic disease appears inferior. CONCLUSIONS: The diagnostic capabilities of WBMRI exceed that of conventional imaging of CT and BS in detecting metastatic disease in patients with HRPCa. However, WBMRI does not perform as well as PSMA PET/CT. Further study on cost comparisons between WBMRI and PSMA PET/CT are needed, as well as evaluations of combined PSMA PET/MRI are needed.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Fang AM, Gregg JR, Pettaway C, et al. Whole-body MRI for staging prostate cancer: a narrative review. BJU Int. 2024. PMID: 39308142. doi:10.1111/bju.16514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。